For patients with COPD, budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol.

Combined airway valve therapy in severe emphysema improves lung function and walking distance for patients with heterogeneous disease, despite some risks.

Exceeds the Upper End of Guidance Range for Full-Year 2024 with Unaudited Global Revenues of Approximately $363.7 Million-- --2025 Global ARIKAYCE Revenues Expected to be Between $405 Million ...

China approves GSK's Nucala for chronic rhinosinusitis with nasal polyps, adding to its existing uses in asthma and other ...

The first step is by far the most tedious. You shouldn’t muck around on the web unless your copy of Windows is fully patched and up to date, period. Now for the bad news: Depending on how long ...

India's winter air quality poses a severe threat to lung health, exacerbating conditions like asthma and COPD. Low temperatures, pollution, and viral infections contribute to increased ...

LOS ANGELES—Noah Hudnut’s family had already spent $150,000 on his psychiatric care when he was hauled in handcuffs by police to the emergency room of UCLA medical center. On top of the ...

This is attributed to increased systemic inflammation. The course of COPD is punctuated by exacerbations, which further increase systemic inflammation, but the risk of vascular events in the ...

ITC share price moved higher by 1 per cent to Rs 475.85 on the BSE in Tuesday's intraday trade, in an otherwise weak market, after the company set January 1, 2025 as the appointed date and the ...

physicians across Canada reported a median wait time of 30.0 weeks between a referral from a GP and receipt of treatment. Up from 27.7 in 2023. This is 222% longer than the 9.3 week wait Canadian ...

A new study found that the C-reactive protein point-of-care test (CRP-POCT) is a low-cost technique for safely lowering antibiotic use in patients with acute exacerbations of COPD (AECOPD). The ...